ACLX FY 2023 Earnings — Arcellx, Inc. Revenue & Financial Results | Market Cap Arena

ACLXArcellx, Inc.

$7B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$110M

Gross Profit

$110M100.0% margin

Operating Income

-$90M-81.5% margin

Net Income

-$71M-64.1% margin

EPS (Diluted)

$-1.47

Cash Flow

Operating Cash Flow

$208M

Free Cash Flow

$186M

Stock-Based Comp.

$42M

Balance Sheet

Total Assets

$825M

Total Liabilities

$340M

Stockholders' Equity

$485M

Cash & Equivalents

$395M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$110M	$0	—
Gross Profit	$110M	-$2M	+5060.4%
Operating Income	-$90M	-$191M	+53.0%
Net Income	-$71M	-$189M	+62.5%